SCHEMBL30106819

SCHEMBL30106819

C=C1CCC(C)(CC(=O)O)C1C

nearest known ligand 0.35

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.35
▸ HSD11B1 P28845 2/20 0.35
▸ PTGS1 P23219 1/20 0.34
▸ GABRA5 P31644 1/20 0.30
▸ GABRB2 P47870 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24704377 0.79 KMT2A (0.39) —
SCHEMBL26000511 0.79 KMT2A (0.39) —
SCHEMBL26000512 0.79 KMT2A (0.39) —
SCHEMBL30114903 0.79 KMT2A (0.39) —
SCHEMBL30114958 0.79 KMT2A (0.39) —
SCHEMBL30108998 0.78 CYP2D6 (0.39) —
SCHEMBL30108872 0.77 ALDH1A1 (0.32) —
SCHEMBL24703992 0.75 — —
SCHEMBL30108857 0.75 PRKCA (0.36) —
SCHEMBL24704186 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4101833-B1 PROCESSES FOR PREPARING A (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETATE COMPOUND AND (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETALDEHYDE SHINETSU CHEMICAL CO (JP) 2023-12-13 — — EP claimed
EP-4101833-B1 PROCESSES FOR PREPARING A (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETATE COMPOUND AND (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETALDEHYDE SHINETSU CHEMICAL CO (JP) 2023-12-13 — — EP disclosed
US-20230002305-A1 PROCESSES FOR PREPARING A (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETATE COMPOUND AND (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETALDEHYDE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-01-05 — — US disclosed
JP-2022188587-A PRODUCTION METHOD OF (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETATE COMPOUND AND (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETALDEHYDE 信越化学工業株式会社 2022-12-21 — — JP disclosed
EP-4101833-A1 PROCESSES FOR PREPARING A (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETATE COMPOUND AND (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETALDEHYDE Shin-Etsu Chemical Co., Ltd. (JP) 2022-12-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002305-A1 PROCESSES FOR PREPARING A (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETATE COMPOUND AND (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETALDEHYDE ADH1C, AKR1C4, AKR1C2 CYP1A2 60/4885HSD11B1 104/4885PTGS1 1715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback